Nanopublication

ID

http://purl.org/np/RAqsy_jgx13zmcoR2I10ir6LEjupK2UmsWyA3DXwV7ZTE
Formats

Content

@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix orcid: <https://orcid.org/> .
@prefix pav: <http://purl.org/pav/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RAqsy_jgx13zmcoR2I10ir6LEjupK2UmsWyA3DXwV7ZTE#> .
@prefix this: <http://purl.org/np/RAqsy_jgx13zmcoR2I10ir6LEjupK2UmsWyA3DXwV7ZTE> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  <http://identifiers.org/pubchem.compound/5073> a biolink:ChemicalEntity;
    rdfs:label "Risperidone";
    biolink:category "biolink:ChemicalEntity";
    biolink:id "PUBCHEM.COMPOUND:5073" .
  
  <http://purl.obolibrary.org/obo/MONDO_0005090> a biolink:DiseaseOrPhenotypicFeature;
    rdfs:label "schizophrenia";
    biolink:category "biolink:DiseaseOrPhenotypicFeature";
    biolink:id "MONDO:0005090" .
  
  sub:_1 a biolink:Association;
    rdf:object <http://purl.obolibrary.org/obo/MONDO_0005090>;
    rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/pubchem.compound/5073>;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category "biolink:Association";
    biolink:id "collaboratory:PUBCHEM.COMPOUND:5073-biolink:treats-MONDO:0005090";
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> .
  
  <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb>
    a biolink:Publication;
    dcterms:type "dctypes";
    biolink:category "biolink:Publication";
    biolink:id "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb" .
  
  infores:knowledge-collaboratory a biolink:InformationResource;
    biolink:category "biolink:InformationResource";
    biolink:id "infores:knowledge-collaboratory" .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2023-02-10T05:42:58.726895"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0003-4727-9435;
    prov:wasQuotedFrom "Risperidone tablets are indicated for the acute and maintenance treatment of schizophrenia" .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCTQs+mANCSHWhIW/YPio468UdGNHsPvADpjfaW8um/v2L4AoDIANginfoU65VNbPT5D0ADt1y0uFNne3VEMr9Y+I2HFaz6IKj+LdYMJk6VUf5WJoImRHIX6BZQwcUc22CbTBFYxvqvp3UmmHrCrhLIZjDSyutExK3tOTRoMDjGowIDAQAB";
    npx:hasSignature "GH8xTR/FIQVzSugFQx7+/8tS4hX4JRasKrhBVqoRBDjDdYkM/A0V4qewlSQqLMJL5B0UXGHGsl+PFuan2XaG8eh1vCpWbPMd00mfT21lc828xX2NbeczotW46Hx/d2TtZ88Aq+ZgU3222GRX22j+iV0mOEJIiuZIhEPxTG4HJDc=";
    npx:hasSignatureTarget this: .
  
  this: dcterms:conformsTo biolink:;
    prov:generatedAtTime "2023-02-10T05:42:58.726895"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0003-4727-9435 .
  
  biolink: pav:version "3.1.0" .
}